This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Surgery, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

A Previously Unreported Adverse Event Associated With Isosulfan Blue

Timothy S. Sadiq, MD; Walter W. Burns III, MD; David J. Taber, PharmD,BCPS; Lynn Damitz, MD; David W. Ollila, MD

Arch Surg. 2001;136:1433-1435.

The sentinel node hypothesis is predicated on the fact that a metastasis, if it exists, will have traveled on a direct path from the primary tumor through the efferent lymphatic channels to the first draining lymph node in the regional lymphatic basin, the sentinel node. Lymphatic mapping with isosulfan blue and sentinel lymphadenectomy is being increasingly used in the management of patients with melanoma, breast cancer, and other solid tumors. This trend is exposing an increasing number of patients to isosulfan blue. Although this compound is generally safe, severe reactions have been reported. We describe 2 patients who developed "blue hives" after isosulfan blue injection.

From the Department of Surgery, University of North Carolina Hospitals, Chapel Hill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2001;136(12):1443-1444.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Blue Dye Indicated for Sentinel Lymph Node Biopsy in Breast Cancer Patients With a Positive Lymphoscintigram?
Degnim et al.
Ann. Surg. Oncol. 2005;12:712-717.
ABSTRACT | FULL TEXT  

Anaphylactic Reactions to Isosulfan Blue Dye During Sentinel Node Lymphadenectomy for Breast Cancer
Sprung et al.
Anesth. Analg. 2003;96:1051-1053.
ABSTRACT | FULL TEXT